Adam Craig, new Garuda Therapeutics CEO
Exclusive: Blood stem cell therapy maker Garuda gets new CEO, adds $47M
Garuda Therapeutics has replaced its top leader and reeled in about $47 million to continue funding its blood stem cell therapy work, Endpoints News has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.